Journal Information
Vol. 44. Issue 1.
Pages 140-141 (January - March 2022)
Share
Share
Download PDF
More article options
Vol. 44. Issue 1.
Pages 140-141 (January - March 2022)
Images in Clinical Hematology
Open Access
Diagnosis of indolent systemic mastocytosis in a patient with “seborrheic keratosis”
Visits
2456
Habib Moshref Razavia,
Corresponding author
habib.moshrefrazavi@fraserhealth.ca

Corresponding author at: Fraser Health Authority, Division of Hematopathology and Transfusion Medicine, Department of Pathology and Laboratory Medicine, The Royal Columbian Hospital, 330 E Columbia St., New Westminster, BC, V3L 3W7, Canada.
, Samuel Kriklerb
a Royal Columbian Hospital, New Westminster, BC, Canada
b Surrey Memorial Hospital, Surrey, BC, Canada
This item has received

Under a Creative Commons license
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Full Text

A 52-year-old female patient is described. The patient was referred to a dermatologist with a two-year history of lesions on her head and neck. She was noted to have red brown, non-scaly, slightly infiltrative papules with a positive Darier's sign, which was biopsy proven to be cutaneous mastocytosis. Further workup showed a markedly elevated serum tryptase levels (58.9 micrograms/L). She denied any abdominal pain, diarrhea, flushing, severe allergic reactions or any other systemic symptoms. In order to rule out systemic mastocytosis a bone marrow biopsy was requested. The CBC and the peripheral smear were unremarkable. A dilute bone marrow aspirate showed normal trilinear hematopoiesis and no evidence of increased myeloblasts or mast cells (Figure 1, panel A). A trephine biopsy showed nodular and paratrabecular mast cell lesions admixed with lymphocytes (Figure 1, panels B and C). Specifically both CD3+ T and CD20 + B-lymphocytes are admixed with the mast cell aggregates (Figure 1, panels D and E). CD34 showed no increase in myeloblasts (Figure 1, panel F). CD117 and tryptase confirmed large mast cell aggregates in the lesions seen on H&E (Figure 1, panels G–I). Quantitative PCR analysis identified the D816V mutation in the KIT gene and with no B or C symptoms the diagnosis of indolent systemic mastocytosis was reached.1 The patient is periodically monitored with imaging, CBCs and serum tryptase levels.

Figure 1.

Bone marrow aspirate and trephine biopsy show the infiltration of a CD117 and tryptase positive mast cell infiltrate admixed with lymphocytes.

(1.09MB).
Conflicts of interest

The authors declare no conflicts of interest.

Reference
[1]
S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, et al.
World Health organization classification of tumours of haematopoietic and lymphoid tissues.
4th ed., International Agency for Research on Cancer, (2017),
Copyright © 2021. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools